Gilead licenses HIV-prevention drug to generic drugmakers

Credit: Pixabay/CC0 Public DomainUS pharmaceutical giant Gilead said Wednesday it had signed licensing deals with six generic drugmakers to produce and sell its HIV prevention medicine in lower-income

Updated on: October 21,2024

Gilead licenses HIV-prevention drug to generic drugmakers

Credit: Pixabay/CC0 Public DomainUS pharmaceutical giant Gilead said Wednesday it had signed licensing deals with six generic drugmakers to produce and sell its HIV prevention medicine in lower-income

Updated on:October 21,2024

Discovery identifies those likely to experience life-threatening dengue fever

by Monash UniversityStudy cohort characteristics. Individuals with a confirmed secondaryDENVinfection were recruited for the study at the onset of fever and followed up for progressio

Updated on: March 13,2024

Discovery identifies those likely to experience life-threatening dengue fever

by Monash UniversityStudy cohort characteristics. Individuals with a confirmed secondaryDENVinfection were recruited for the study at the onset of fever and followed up for progressio

Updated on:March 13,2024

SARS-CoV-2 studies: Only neutralizing antibodies allow conclusions to be drawn about protection against new infections

by Medical University of ViennaPrinciple of cell-culture-based neutralization assays. (A) Conventional virus-neutralization test (VNT) and (B) pseudovirus-neutralization test (pVNT) are laborator

Updated on: April 22,2024

SARS-CoV-2 studies: Only neutralizing antibodies allow conclusions to be drawn about protection against new infections

by Medical University of ViennaPrinciple of cell-culture-based neutralization assays. (A) Conventional virus-neutralization test (VNT) and (B) pseudovirus-neutralization test (pVNT) are laborator

Updated on:April 22,2024

How dangerous is the mpox clade Ib public health emergency? | News Desk

Updated on: August 29,2024

How dangerous is the mpox clade Ib public health emergency? | News Desk

Updated on:August 29,2024

New study highlights importance of targeting unchanging parts of COVID-19 virus

byCorewell HealthCorewell Health COVID-19 sequencing data. (A) Sequencing statistics for samples analyzed at Corewell Health using Illumina chemistry. (B) SARS-CoV-2 genotypes per month from Dec

Updated on: October 05,2024

New study highlights importance of targeting unchanging parts of COVID-19 virus

byCorewell HealthCorewell Health COVID-19 sequencing data. (A) Sequencing statistics for samples analyzed at Corewell Health using Illumina chemistry. (B) SARS-CoV-2 genotypes per month from Dec

Updated on:October 05,2024

Phase 3 clinical trial: Second-generation COVID vaccine generates high levels of neutralizing antibodies

by University of Washington School of MedicineVaccine GPB510 is a tiny ball of protein studded with 60 copies of the SARS-CoV-2 Spike protein receptor-binding domain (red). Credit: Ian Haydon / U

Updated on: April 02,2024

Phase 3 clinical trial: Second-generation COVID vaccine generates high levels of neutralizing antibodies

by University of Washington School of MedicineVaccine GPB510 is a tiny ball of protein studded with 60 copies of the SARS-CoV-2 Spike protein receptor-binding domain (red). Credit: Ian Haydon / U

Updated on:April 02,2024

WHO launches plan to rein in 'alarming' dengue spread

This transmission electron microscopic (TEM) image depicts a number of round, Dengue virus particles that were revealed in this tissue specimen. Credit: CDC/ Frederick MurphyThe World Health Organizat

Updated on: November 15,2024

WHO launches plan to rein in 'alarming' dengue spread

This transmission electron microscopic (TEM) image depicts a number of round, Dengue virus particles that were revealed in this tissue specimen. Credit: CDC/ Frederick MurphyThe World Health Organizat

Updated on:November 15,2024

HIV: An antidiabetic drug to reduce chronic inflammation

by University of Montreal Hospital Research CentreScanning electromicrograph of an HIV-infected T cell. Credit: NIAIDMetformin, a drug used to treat type-2 diabetes, could help reduce chronic inflamma

Updated on: April 16,2024

HIV: An antidiabetic drug to reduce chronic inflammation

by University of Montreal Hospital Research CentreScanning electromicrograph of an HIV-infected T cell. Credit: NIAIDMetformin, a drug used to treat type-2 diabetes, could help reduce chronic inflamma

Updated on:April 16,2024

Scientists find new, better way to develop vaccines

byOxford University PressCredit: CC0 Public DomainAnew paperinBiology Methods & Protocolsindicates that researchers in Germany have developed a new system to display

Updated on: January 26,2024

Scientists find new, better way to develop vaccines

byOxford University PressCredit: CC0 Public DomainAnew paperinBiology Methods & Protocolsindicates that researchers in Germany have developed a new system to display

Updated on:January 26,2024

How does SARS-CoV-2 evade our immune defenses?

by John Hewitt , Medical XpressColorized scanning electron micrograph of a cell (blue) heavily infected with SARS-CoV-2 virus particles (red), isolated from a patient sample. Image captured at the NIA

Updated on: April 22,2024

How does SARS-CoV-2 evade our immune defenses?

by John Hewitt , Medical XpressColorized scanning electron micrograph of a cell (blue) heavily infected with SARS-CoV-2 virus particles (red), isolated from a patient sample. Image captured at the NIA

Updated on:April 22,2024

The antibodies of 'post-treatment HIV controllers'

by Pasteur InstituteCredit: Pixabay/CC0 Public DomainA very small percentage of people with HIV-1, known as "post-treatment controllers" (PTCs), are able to control their infection afte

Updated on: April 01,2024

The antibodies of 'post-treatment HIV controllers'

by Pasteur InstituteCredit: Pixabay/CC0 Public DomainA very small percentage of people with HIV-1, known as "post-treatment controllers" (PTCs), are able to control their infection afte

Updated on:April 01,2024

Study explores characteristics associated with poor COVID-19 antibody response

by Melissa Rohman,Northwestern UniversityAnti-S1 IgG levels over time between first vaccine dose and serosurvey by socio-demographic and clinical correlates. Plot of predicted anti-S1 antibody l

Updated on: March 27,2024

Study explores characteristics associated with poor COVID-19 antibody response

by Melissa Rohman,Northwestern UniversityAnti-S1 IgG levels over time between first vaccine dose and serosurvey by socio-demographic and clinical correlates. Plot of predicted anti-S1 antibody l

Updated on:March 27,2024